Behavioral changes often accompany the autoimmune disease systemic lupus erythematosus (SLE) in humans and animals. In a mouse model of SLE, the NZB 1 NZW F1 (B/W) hybrid, 12-week-old mice display more anxiety behavior, less activity, and less exploratory behavior than non-autoimmune female NZW mice. To determine whether these behaviors result from the autoimmune disease or genetic differences between B/W and NZW mice, they were assessed prior to and during disease emergence (6 and 12 weeks of age, respectively). B/W mice were less active at both ages, suggesting a genetic component to this behavioral difference. Anxiety behavior and exploratory behavior did not differ between B/W and NZW mice at 6 weeks; however, at 12 weeks B/W mice displayed more anxiety behavior and less exploratory behavior, indicating that these behaviors were related with the development of autoimmune disease. Prior experience with these tasks increased anxiety behavior in B/W but not NZW mice, suggesting that B/W mice may be more sensitive to anxiogenic experiences. ᭧
INTRODUCTION
Systemic lupus erythematosus (SLE) is a devastating autoimmune disease primarily affecting postpubertal, premenopausal women. It is characterized by alterations in humoral and cellular immune responses, including dysregulation of the cytokine network. The associated autoantibodies and immune complexes result in considerable tissue damage and often death (reviewed by Ferrell & Tan, 1985; Reichlin, 1991) . Chronic disorders of the immune system such as SLE are often accompanied by behavioral changes including dementia, memory loss, affective disorders, and anxiety (Carr, Shucard, Hoffman, Hoffman, Bardana, & Harbeck, 1978; Denburg, Carbotte, & Denburg, 1987; Denburg, Carbotte, Long, & Denburg, 1988; Iverson, 1993; Lim, Ron, Ormerod, David, Miller, Logsdail, Walport, & Harding, 1988) . These behavioral pathologies can persist throughout the disease and be highly disruptive to daily life. Nervous system dysfunction has been found in 25-75% of SLE patients and is a diagnostic criterion (Tan, Cohen, Fries, Masi, McShane, Rothfield, Schaller, Talal, & Winchester, 1982) . Behavioral manifestations include cognitive deficits, affective disorders, and anxiety (Carr et al., 1978; Denburg et al., 1987; 1988; Iverson, 1993; Lim et al., 1988) . However, knowledge that one has a potentially fatal disease, lifestyle changes which accompany a chronic disease, as well as treatments with mood-altering medications make it difficult to relate behavioral symptoms to disease pathology in
